Preventing early-onset group B streptococcal sepsis: is there a role for rescreening near term?

2019 ◽  
Vol 33 (22) ◽  
pp. 3791-3797 ◽  
Author(s):  
Rachel Mirsky ◽  
Diane M. Carpenter ◽  
Debbie A. Postlethwaite ◽  
Anne C. Regenstein
Keyword(s):  
Early Onset ◽  
Streptococcal Sepsis ◽  
Near Term ◽  
Group B ◽  
Onset Group ◽  
Early Onset Group

scholarly journals THE INFLUENCE OF LEUKOPENIA ON SURVIVAL IN EARLY ONSET GROUP B STREPTOCOCCAL SEPSIS

1977 ◽  
Vol 11 (4) ◽  
pp. 497-497
Author(s):  
Robert P Bacsik ◽  
Larry N Cook ◽  
Roger J Shott ◽  
Billy F Andrews
Keyword(s):  
Early Onset ◽  
Streptococcal Sepsis ◽  
Group B ◽  
Onset Group ◽  
Early Onset Group

Outbreak of early onset Group B streptococcal sepsis

1993 ◽  
Vol 12 (7) ◽  
pp. 565-570 ◽  
Author(s):  
WILLIAM G. ADAMS ◽  
JANET S. KINNEY ◽  
ANNE SCHUCHAT ◽  
CARYL L. COLLIER ◽  
CHRISTOPHER J. PAPASIAN ◽  
...  
Keyword(s):  
Early Onset ◽  
Streptococcal Sepsis ◽  
Group B ◽  
Onset Group ◽  
Early Onset Group

ECMO and Sepsis

PEDIATRICS ◽  
1992 ◽  
Vol 90 (1) ◽  
pp. 127-127
Author(s):  
MICHAEL H. LEBLANC
Keyword(s):  
Extracorporeal Membrane Oxygenation ◽  
Early Onset ◽  
Membrane Oxygenation ◽  
Streptococcal Sepsis ◽  
Group B ◽  
Onset Group ◽  
Early Onset Group ◽  
Ecmo Therapy

To the Editor.— The article by Hocker et al, "Extracorporeal Membrane Oxygenation and Early Onset Group B Streptococcal Sepsis,"1 purports to show that extracorporeal membrane oxygenation (ECMO) is effective in Group B Sepsis. The study begins comparing results prior to ECMO therapy with results after ECMO therapy. The incidence of death from Group B Sepsis went from 3 of 28 or 11% prior to the institution of ECMO to 9 of 53 or 17% after the institution of ECMO.

ECMO for Infection

PEDIATRICS ◽  
1992 ◽  
Vol 90 (1) ◽  
pp. 127-128
Author(s):  
DAVID G. FISHER
Keyword(s):  
Risk Factors ◽  
Early Onset ◽  
Streptococcal Infection ◽  
Controlled Trial ◽  
Streptococcal Sepsis ◽  
Group B ◽  
Onset Group ◽  
Historical Controls ◽  
Early Onset Group

To the Editor.— Dr Hocker and his colleagues1 are to be commended for taking on the difficult task of evaluating the success of ECMO in early-onset group B streptococcal infection when a controlled trial is ethically and practically not feasible. In their study they used historical controls (a commonly criticized method, but all that is realistically available) to identify risk factors for early-onset group B streptococcal sepsis and to evaluate the effectiveness of ECMO intervention.

Sign in / Sign up

Export Citation Format

Share Document